611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Morphine Effects Similar to Placebo in Rheumatoid ArthritisHealth Tip: Learn Your Risk for AsthmaEczema Can Take a Toll on AdultsAOSSM: New Surgical Option for Irreparable Rotator Cuff TearsDrug Beats Steroids for Controlling Blood Vessel Inflammation in StudyNew Surgery May Fix Tough-to-Treat Rotator Cuff TearsNearly All Autopsied NFL Players Show Trauma-Linked Brain DiseaseMany Primary Care Docs May Miss PrediabetesIs the 'Anti-Statin' Trend Threatening Lives?Obese Don't Have to Lose Weight Before Joint Replacement: StudyDoes Your Child Really Have a Food Allergy?Health Tip: Adapting After Hip ReplacementHealth Tip: If Heartburn Doesn't Go AwayBlame Diabetes: Rates of 2 Nerve Conditions on the RiseSurgery for ACL Tear Often Successful Over Long TermEHR-Based Prompt Ups Hepatitis C Screening for Baby BoomersTravelers to Europe Need Measles Protection: CDCLaser Therapy Shows Promise Against Eye 'Floaters'Health Tip: Ease the Pain of a BlisterChronic Disease Risk Rises With Even Slow, Steady Weight GainAs Your Weight Creeps Up, So Does Your Risk of Heart FailureResearchers Grow Functioning Liver Tissue in MiceMore Than 100 Million Americans Have Diabetes or Prediabetes: CDCMeasles Outbreak Identified in Minnesota Is OngoingMore Evidence That Midlife Weight Gain Harms Your HealthReducing Repeat Hospitalizations Doesn't Harm Patients: StudyImpaired Eyesight May Be First Sign of Zika Damage in BabiesSome Medicines Boost Sensitivity to Sun9/11 Survivors More Likely to Have Heart, Lung DiseasesCould Artificial Sweeteners Raise Your Odds for Obesity?Many Americans Unaware of This Year's Heavy Tick Season: PollAfter Sunburn, High-Dose Vitamin D Cuts Inflammatory MediatorsHealth Tip: At Risk of Heat Illness?Working Too Much Might Tip Heart Into Irregular RhythmQuitting Smoking Can Bring Healthier Sinuses Years Later: StudyThyroid Problems May Make Things Worse for Dialysis PatientsWhite Collar Workers at Higher Odds of Death From ALS, Parkinson'sExperimental Vaccines Might Shield Fetus From ZikaStudy Spots Cause of Global Outbreak of Infections Tied to Heart SurgeriesEducation Can Boost Knowledge, Cut Anxiety in GlaucomaReview: Little Evidence on Vitamin D-Allergy AssociationClimate Change Delivers 'Double Whammy' to 4 in 10 AmericansHealth Tip: Battling Muscle Cramps?Too Few Children Get EpiPen When Needed: StudyCPAP Mask Not a Prescription for Heart TroublesNew Criteria Urged for Infection Diagnosis Among Seniors in EREarly Parkinson's May Prompt Vision ProblemsParkinson's Patients Deemed at Higher Risk of MelanomaViagra Might Make for a Safer, More Effective StentDaily Jolt of Java May Bring Longer Life
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

PCSK9 Linked to New-Onset Diabetes After Renal Transplant


HealthDay News
Updated: May 9th 2017

new article illustration

TUESDAY, May 9, 2017 (HealthDay News) -- For renal transplant recipients (RTRs) without diabetes, circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with new-onset diabetes after transplantation (NODAT), according to a study published online May 1 in Diabetes Care.

Michele F. Eisenga, M.D., from the University of Groningen in the Netherlands, and colleagues examined the correlation between serum PCSK9 levels and NODAT development among RTRs without diabetes with a functional graft for at least one year.

Serum PCSK9 was 107.1 ± 43.4 µg/L in 453 RTRs. The researchers found that 70 RTRs developed NODAT, 123 died, and 59 developed graft failure during a median follow-up of 10 years. NODAT occurred more often in the upper versus the two lowest tertiles of PCSK9 (23 versus 12 percent; P < 0.001). PCSK9 correlated with the development of NODAT (hazard ratio, 1.34; 95 percent confidence interval, 1.10 to 1.63 per standard deviation change; P = 0.004). The correlation was independent of confounding variables, including statin use. There was no correlation for PCSK9 with all-cause mortality, cardiovascular mortality, or graft failure.

"Circulating PCSK9 is associated with NODAT in RTRs," the authors write. "The PCSK9 pathway may contribute to the pathogenesis of NODAT."

PCSK9 was measured at Lilly Research Laboratories (Eli Lilly and Company) for free.

Abstract/Full Text (subscription or payment may be required)